p.123 抽出テキスト

underlying familial sick sinus syndrome with early onset and predominantly male characteristics. Circ Arrhythm Electrophysiol 2014; 7: 511-517. PMID: 24762805 775. Makita N, Sasaki K, Groenewegen WA, et al. Congenital atrial standstill associated with coinheritance of a novel SCN5A mutation and connexin 40 polymorphisms. Heart Rhythm 2005; 2: 1128- 1134. PMID: 16188595 776. Milanesi R, Baruscotti M, Gnecchi-Ruscone T, et al. Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N Engl J Med 2006; 354: 151-157. PMID: 16407510 777. Ishikawa T, Jou CJ, Nogami A, et al. Novel mutation in the α -myosin heavy chain gene is associated with sick sinus syndrome. Circ Arrhythm Electrophysiol 2015; 8: 400-408. PMID: 25717017 778. Holm H, Gudbjartsson DF, Sulem P, et al. A rare variant in MYH6 is associated with high risk of sick sinus syndrome. Nat Genet 2011; 43: 316-320. PMID: 21378987 779. Thorolfsdottir RB, Sveinbjornsson G, Aegisdottir HM, et al. Genetic insight into sick sinus syndrome. Eur Heart J 2021; 42: 1959-1971. PMID: 33580673 780. Weng LC, Rämö JT, Jurgens SJ, et al. The impact of common and rare genetic variants on bradyarrhythmia development. Nat Genet 2025; 57: 53-64. PMID: 39747593 781. Nishiuchi S, Makiyama T, Aiba T, et al. Gene-Based Risk Stratification for Cardiac Disorders in LMNA Mutation Carriers. Circ Cardiovasc Genet 2017; 10: e001603. PMID: 29237675 782. Mohler PJ, Schott JJ, Gramolini AO, et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003; 421: 634-639. PMID: 12571597 783. Stallmeyer B, Kuß J, Kotthoff S, et al. A Mutation in the G-Protein Gene GNB2 Causes Familial Sinus Node and Atrioventricular Conduction Dysfunction. Circ Res 2017; 120: e33-e44. PMID: 28219978 784. Nomura Y, Ishikawa T, Ohno S, et al. Atypical Holt-Oram syndrome: Early-onset sick sinus syndrome in a Japanese family with a novel TBX5 mutation, Q469. J Cardiol Cases 2025; 32: 10-14. PMID: 40697198 785. Li N, Wang ZS, Wang XH, et al. A SHOX2 loss-of-function mutation underlying familial atrial fibrillation. Int J Med Sci 2018; 15: 1564-1572. PMID: 30443179 786. Hoffmann S, Paone C, Sumer SA, et al. Functional Characterization of Rare Variants in the SHOX2 Gene Identified in Sinus Node Dysfunction and Atrial Fibrillation. Front Genet 2019; 10: 648. PMID: 31354791 787. Daley WR, Kaczmarek RG. The epidemiology of cardiac pacemakers in the older US population. J Am Geriatr Soc 1998; 46: 1016-1019. PMID: 9706894 788. Schweizer PA, Schröter J, Greiner S, et al. The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel. J Am Coll Cardiol 2014; 64: 757-767. PMID: 25145518 789. Milano A, Vermeer AM, Lodder EM, et al. HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy. J Am Coll Cardiol 2014; 64: 745-756. PMID: 25145517 790. Li QY, Newbury-Ecob RA, Terrett JA, et al. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet 1997; 15: 21-29. PMID: 8988164 791. Postma AV, van de Meerakker JB, Mathijssen IB, et al. A gain-offunction TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation. Circ Res 2008; 102: 1433-1442. PMID: 18451335 792. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988; 318: 129-133. PMID: 3336399 793. Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm 2019; 16: e301-e372. PMID: 31078652 794. Arbelo E, Protonotarios A, Gimeno JR, et al. ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J 2023; 44: 3503-3626. PMID: 37622657 795. McKenna WJ, Maron BJ, Thiene G. Classification, Epidemiology, and Global Burden of Cardiomyopathies. Circ Res 2017; 121: 722-730. PMID: 28912179 796. McKenna WJ, Judge DP. Epidemiology of the inherited cardiomyopathies. Nat Rev Cardiol 2021; 18: 22-36. PMID: 32895535 797. Bosman LP, Te Riele ASJM. Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification. Heart 2022; 108: 90-97. PMID: 33990412 798. Basso C, Corrado D, Marcus FI, et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009; 373: 1289-1300. PMID: 19362677 799. Protonotarios A, Anastasakis A, Panagiotakos DB, et al. Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy. Europace 2016; 18: 610-616. PMID: 25825460 800. Corrado D, Link MS, Calkins H. Arrhythmogenic Right Ventricular Cardiomyopathy. N Engl J Med 2017; 376: 61-72. PMID: 28052233 801. Wada Y, Ohno S, Aiba T, et al. Unique genetic background and outcome of non-Caucasian Japanese probands with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Mol Genet Genomic Med 2017; 5: 639-651. PMID: 29178656 802. James CA, Jongbloed JDH, Hershberger RE, et al. International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework. Circ Genom Precis Med 2021; 14: e003273. PMID: 33831308 803. Protonotarios N, Tsatsopoulou A. Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Pathol 2004; 13: 185-194. PMID: 15210133 804. Chen L, Rao M, Chen X, et al. A founder homozygous DSG2 variant in East Asia results in ARVC with full penetrance and heart failure phenotype. Int J Cardiol 2019; 274: 263-270. PMID: 30454721 805. Zankov DP, Batbaatar MA, Tsuchimochi H, et al. Biventricular Dysfunction in Knock-in Mice With Dsg2 Variants Specific for Japanese Arrhythmogenic Right Ventricular Cardiomyopathy. Circ J 2025; 90: 126-133. PMID: 40887256 806. Smith ED, Lakdawala NK, Papoutsidakis N, et al. Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation 2020; 141: 1872-1884. PMID: 32372669 807. Gasperetti A, Carrick RT, Protonotarios A, et al. Clinical features and outcomes in carriers of pathogenic desmoplakin variants. Eur Heart J 2025; 46: 362-376. PMID: 39288222 808. Carvajal-Huerta L. Epidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy. J Am Acad Dermatol 1998; 39: 418-421. PMID: 9738775 809. Norgett EE, Hatsell SJ, Carvajal-Huerta L, et al. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet 2000; 9: 2761-2766. PMID: 11063735 810. Christensen AH, Platonov PG, Jensen HK, et al. Genotypephenotype correlation in arrhythmogenic right ventricular cardiomyopathy-risk of arrhythmias and heart failure. J Med Genet 2022; 59: 858-864. PMID: 34400560 811. Hermida A, Fressart V, Hidden-Lucet F, et al. High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur J Heart Fail 2019; 21: 792-800. PMID: 30790397 812. Chen L, Hu Y, Saguner AM, et. al. Natural History and Clinical Outcomes of Patients With DSG2/DSC2 Variant-Related Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation 2025; 151: 1213-1230. PMID: 40123482 813. Coonar AS, Protonotarios N, Tsatsopoulou A, et al. Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation 1998; 97: 2049-2058. PMID: 9610536 814. McKoy G, Protonotarios N, Crosby A, et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000; 355: 2119-2124. PMID: 10902626 815. Merner ND, Hodgkinson KA, Haywood AF, et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet 2008; 82: 809-821. PMID: 18313022 816. Hodgkinson KA, Howes AJ, Boland P, et al. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy. Circ Arrhythm Electrophysiol 2016; 9: e003589. PMID: 26966288 817. Verstraelen TE, van Lint FHM, Bosman LP, et al. Prediction of